Form 4: Electromed Director Andrew Summers Sells Shares in Multiple Transactions

Director Andrew Summers sold a significant number of Electromed, Inc. shares through multiple transactions on December 5, 2024, via Summers Value Fund LP and SVP Deal Fund I LP.

Summary

• Andrew Summers, a director of Electromed, Inc., sold shares of the company's common stock on December 5, 2024.
• The sales were executed through two entities: Summers Value Fund LP and SVP Deal Fund I LP.
• A total of 36,245 shares were sold through Summers Value Fund LP at weighted average prices ranging from $28.0877 to $29.4094.
• A total of 19,098 shares were sold through SVP Deal Fund I LP at weighted average prices ranging from $28.0855 to $29.4034.
• The transactions were conducted in multiple trades at varying prices within the specified ranges.
• Following these transactions, Summers Value Fund LP holds 300,629 shares and SVP Deal Fund I LP holds 146,827 shares.
• Mr. Summers disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the sale of shares by a director, which could be interpreted as a lack of confidence. However, it's a routine disclosure and not necessarily indicative of a major issue.

Negatives

• A director selling a significant number of shares could be perceived negatively by the market.

Risks

• The sale of shares by a director could indicate a lack of confidence in the company's future performance.
• Large sales by insiders can sometimes lead to downward pressure on the stock price.

Management Comments

• Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Industry Context

Insider trading activity is a common occurrence in the stock market, and this filing is a routine disclosure of such activity. It is important to monitor insider transactions as they can sometimes provide insights into management's view of the company's prospects.

Comparison to Industry Standards

• It is common for directors and officers to trade shares of their companies, and these transactions are typically disclosed through SEC filings.
• The volume of shares sold by Andrew Summers is significant, but not unusual for a director with substantial holdings.
• Comparable companies would also have similar filings when directors or officers trade shares.

Stakeholder Impact

• Shareholders may react to the news of a director selling shares, potentially impacting the stock price.
• The sale does not directly impact employees, customers, or suppliers.

Key Dates

Keywords

Electromed, ELMD, Andrew Summers, insider trading, share sale, Summers Value Fund LP, SVP Deal Fund I LP, director, SEC Form 4